Motoyama Daisuke, Watanabe Kyohei, Matsushita Yuto, Watanabe Hiromitsu, Tamura Keita, Miyake Hideaki, Inamoto Teruo
Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu 431-3192, Japan.
Department of Developed Studies for Advanced Robotic Surgery, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
J Clin Med. 2025 Aug 19;14(16):5850. doi: 10.3390/jcm14165850.
: This study aimed to evaluate and compare the perioperative outcomes of robot-assisted partial nephrectomy (RAPN) for complex renal tumors performed using the novel Japanese Hinotori Surgical Robot System (HSRS) and the established Da Vinci Surgical System (DVSS). : Of 484 consecutive patients who underwent RAPN at our institution, 126 with complex renal tumors were included in the DVSS group, and 48 such patients were included in the HSRS group. Complex tumors in this series were defined by the presence of at least one of the following factors: cT1b, completely endophytic, hilar, cystic, or ipsilateral multiple tumors. : Following 1:2 propensity score matching, 74 and 37 patients were included in the DVSS and HSRS groups, respectively. Post-matching, most covariates' absolute standardized mean difference (SMD) was less than 0.1, indicating effective baseline imbalance correction. All RAPN procedures using HSRS were completed without conversion to open surgery, nephrectomy, or Clavien-Dindo ≥3 postoperative complications. No significant differences in major perioperative outcomes were observed between DVSS and HSRS, including operative time (178 vs. 186 min), console time (115 vs. 115 min; encompassing cockpit time for HSRS), warm ischemia time (15 vs. 15 min), and estimated blood loss (51 vs. 30 mL). Positive surgical margin rates (DVSS 1.4% vs. HSRS 5.4%) and Trifecta achievement rates (94.6% vs. 91.9%) were also comparable, with no significant differences. : These findings suggest that, even in patients with complex renal tumors, RAPN performed using the HSRS can achieve perioperative outcomes comparable to those obtained with the established DVSS.
本研究旨在评估和比较使用新型日本日之鸟手术机器人系统(HSRS)和成熟的达芬奇手术系统(DVSS)进行复杂肾肿瘤机器人辅助部分肾切除术(RAPN)的围手术期结果。在我们机构连续接受RAPN的484例患者中,126例患有复杂肾肿瘤的患者被纳入DVSS组,48例此类患者被纳入HSRS组。本系列中的复杂肿瘤由以下至少一个因素定义:cT1b、完全内生、肾门、囊性或同侧多发肿瘤。经过1:2倾向评分匹配后,DVSS组和HSRS组分别纳入74例和37例患者。匹配后,大多数协变量的绝对标准化均值差(SMD)小于0.1,表明有效的基线不平衡校正。所有使用HSRS的RAPN手术均顺利完成,未转为开放手术、肾切除术或Clavien-Dindo≥3级术后并发症。DVSS和HSRS之间在主要围手术期结果方面未观察到显著差异,包括手术时间(178 vs. 186分钟)、控制台时间(115 vs. 115分钟;HSRS包括驾驶舱时间)、热缺血时间(15 vs. 15分钟)和估计失血量(51 vs. 30毫升)。阳性手术切缘率(DVSS 1.4% vs. HSRS 5.4%)和三联成功达成率(94.6% vs. 91.9%)也具有可比性,无显著差异。这些发现表明,即使在患有复杂肾肿瘤的患者中,使用HSRS进行的RAPN也能实现与成熟的DVSS相当的围手术期结果。